Canada Markets closed

Insiders who bought stock earlier this year lose -CA$129k as Perimeter Medical Imaging AI, Inc. (CVE:PINK) drops to CA$143m

  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Insiders who acquired CA$587k worth of Perimeter Medical Imaging AI, Inc.'s (CVE:PINK) stock at an average price of CA$2.92 in the past 12 months may be dismayed by the recent 16% price decline. This is not good as insiders invest based on expectations that their money will appreciate over time. However, as a result of recent losses, their original investment is now worth only CA$459k.

While insider transactions are not the most important thing when it comes to long-term investing, logic dictates you should pay some attention to whether insiders are buying or selling shares.

Check out our latest analysis for Perimeter Medical Imaging AI

The Last 12 Months Of Insider Transactions At Perimeter Medical Imaging AI

The Independent Director Aaron Davidson made the biggest insider purchase in the last 12 months. That single transaction was for CA$252k worth of shares at a price of CA$3.00 each. So it's clear an insider wanted to buy, even at a higher price than the current share price (being CA$2.28). Their view may have changed since then, but at least it shows they felt optimistic at the time. In our view, the price an insider pays for shares is very important. It is generally more encouraging if they paid above the current price, as it suggests they saw value, even at higher levels.

In the last twelve months Perimeter Medical Imaging AI insiders were buying shares, but not selling. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

insider-trading-volume
insider-trading-volume

Perimeter Medical Imaging AI is not the only stock insiders are buying. So take a peek at this free list of growing companies with insider buying.

Insider Ownership of Perimeter Medical Imaging AI

I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. Our data suggests Perimeter Medical Imaging AI insiders own 0.9% of the company, worth about CA$1.3m. We prefer to see high levels of insider ownership.

What Might The Insider Transactions At Perimeter Medical Imaging AI Tell Us?

It doesn't really mean much that no insider has traded Perimeter Medical Imaging AI shares in the last quarter. However, our analysis of transactions over the last year is heartening. The transactions are fine but it'd be more encouraging if Perimeter Medical Imaging AI insiders bought more shares in the company. While we like knowing what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. To help with this, we've discovered 5 warning signs (2 are a bit concerning!) that you ought to be aware of before buying any shares in Perimeter Medical Imaging AI.

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting